Looking Ahead to Healthcare in 2021 & Beyond
2020 was an extremely challenging and pivotal year for the healthcare and life sciences industry. With a global pandemic that impacted the lives of millions, payors, providers and pharmaceutical companies were forced to quickly adapt to address the crisis. Now as COVID-19 infections are starting to slow, we can turn our attention to the future. Below, we explore some of the trends that will continue to affect the healthcare market this year and beyond.
Enhancements to longstanding policy statutes, coupled with the outcome of the 2020 U.S. presidential election, have begun to shift the future of healthcare as we know it.
COVID-19 brought a new wave of initiatives and workflows in the clinical trial and vaccination process that will alter the industry for the better.
The Future of Pharma: mRNA Technology and the Next Big Launch
The potential of mRNA technology is limitless, shifting from being used primarily in the development of COVID-19 vaccines to earning a leading role in the life sciences industry of today.
The Evolution of the Vaccine Lifecycle
From vaccine monitoring to intelligent vaccine distribution, learn how pharmaceutical companies can reflect on lessons learned from COVID-19 and adapt for the future.
Payors and providers were already considering adding telemedicine capabilities, but, thanks to COVID-19, offering these capabilities became a business imperative. For telemedicine to be effective, the industry needs to adopt meaningful digital therapeutics.
Telemedicine: The New Normal & Strategic Lever for Healthcare
How can healthcare leaders lean into telemedicine and scale capabilities that embrace AI, machine learning and computer vision?
EPAM & Curogram Partner to Scale COVID-19 Crisis Response Telemedicine Platform
Healthcare institutions can quickly deploy mass screening and testing services through Curogram’s two-way texting and video chat platform enabled by EPAM’s implementation services.
Regulation has long hindered the emergence of dominant digital consumer platforms in healthcare. With the recent removal of policy roadblocks as well as COVID-19 providing a proof point for their value, we are starting to see them mature before our eyes.